G I bleeding with radiological interventions(ACR Appropriateness Criteria).Tc-99m RBC scintigraphy,Catheter-directed Angiography,Pharmacological control,Embolization,Arterial interventions,Endoscopy,CT Angiography
This document provides an overview of approaches to gastrointestinal bleeding. It discusses the common clinical presentations including hematemesis, melena, hematochezia, and occult bleeding. For hematemesis, the most common causes are discussed such as stress ulcers, Mallory-Weiss tears, peptic ulcer disease, gastroesophageal varices, and Dieulafoy's lesion. For hematochezia, common causes include colonic diverticula, internal hemorrhoids, colon cancer, and inflammatory bowel disease. The document provides details on evaluating each potential cause and characteristics to consider in the clinical history and examination.
Upper GI bleeding refers to bleeding that originates in the esophagus, stomach, or duodenum. Common causes include peptic ulcers, esophageal varices, and gastritis. Risk factors include NSAID/aspirin use and H. pylori infection. Diagnosis involves history, physical exam, endoscopy, and blood tests. Management depends on risk level and includes hemodynamic stabilization, endoscopy, and treatment of the underlying cause. Outcomes range from full recovery to mortality rates as high as 30% in severe or continuing bleeding cases.
1. The document discusses gastrointestinal bleeding, describing different types including hematemesis, melena, hematochezia, occult blood, and chronic blood loss.
2. It examines causes of upper and lower GI bleeding such as peptic ulcers, varices, hemorrhoids, and tumors.
3. Evaluation and management are outlined, including resuscitation of hypovolemic shock, determining bleeding location, and considering high risk patients.
Dr. Darpan Nepali presented on the gastrointestinal system, specifically on the causes, diagnosis, and management of upper gastrointestinal bleeding. The presentation reviewed the major causes of upper GI bleeding including esophageal and gastric sources. Initial management focuses on resuscitation, risk stratification using scoring systems, and urgent endoscopy. Endoscopic findings and scoring systems can help determine need for hemostatic therapy and predict rebleeding risk. Management differs for variceal versus non-variceal bleeding sources.
This document discusses the pathophysiology of upper GI bleeding. It describes how portal hypertension can lead to esophageal varices and the development of portosystemic collaterals. It also discusses how peptic ulcer disease associated with H. pylori infection can cause ulcers that weaken blood vessels and rupture. Acute stress gastritis is described as resulting from conditions that alter mucosal barriers like decreased blood flow or ischemia from shock/trauma. Mallory-Weiss tears occur when forceful vomiting causes tears in the gastric mucosa at the gastroesophageal junction.
Gastrointestinal (GI) bleeding refers to any bleeding that originates in the GI tract, ranging from microscopic to massive bleeding. GI bleeding can occur from the mouth to the anus and have various causes including ulcers, cancers, and vascular abnormalities. Signs of upper GI bleeding include vomiting blood while signs of lower GI bleeding include bloody stool. Management may involve blood transfusions, endoscopy, and surgery to control active bleeding.
G I bleeding with radiological interventions(ACR Appropriateness Criteria).Tc-99m RBC scintigraphy,Catheter-directed Angiography,Pharmacological control,Embolization,Arterial interventions,Endoscopy,CT Angiography
This document provides an overview of approaches to gastrointestinal bleeding. It discusses the common clinical presentations including hematemesis, melena, hematochezia, and occult bleeding. For hematemesis, the most common causes are discussed such as stress ulcers, Mallory-Weiss tears, peptic ulcer disease, gastroesophageal varices, and Dieulafoy's lesion. For hematochezia, common causes include colonic diverticula, internal hemorrhoids, colon cancer, and inflammatory bowel disease. The document provides details on evaluating each potential cause and characteristics to consider in the clinical history and examination.
Upper GI bleeding refers to bleeding that originates in the esophagus, stomach, or duodenum. Common causes include peptic ulcers, esophageal varices, and gastritis. Risk factors include NSAID/aspirin use and H. pylori infection. Diagnosis involves history, physical exam, endoscopy, and blood tests. Management depends on risk level and includes hemodynamic stabilization, endoscopy, and treatment of the underlying cause. Outcomes range from full recovery to mortality rates as high as 30% in severe or continuing bleeding cases.
1. The document discusses gastrointestinal bleeding, describing different types including hematemesis, melena, hematochezia, occult blood, and chronic blood loss.
2. It examines causes of upper and lower GI bleeding such as peptic ulcers, varices, hemorrhoids, and tumors.
3. Evaluation and management are outlined, including resuscitation of hypovolemic shock, determining bleeding location, and considering high risk patients.
Dr. Darpan Nepali presented on the gastrointestinal system, specifically on the causes, diagnosis, and management of upper gastrointestinal bleeding. The presentation reviewed the major causes of upper GI bleeding including esophageal and gastric sources. Initial management focuses on resuscitation, risk stratification using scoring systems, and urgent endoscopy. Endoscopic findings and scoring systems can help determine need for hemostatic therapy and predict rebleeding risk. Management differs for variceal versus non-variceal bleeding sources.
This document discusses the pathophysiology of upper GI bleeding. It describes how portal hypertension can lead to esophageal varices and the development of portosystemic collaterals. It also discusses how peptic ulcer disease associated with H. pylori infection can cause ulcers that weaken blood vessels and rupture. Acute stress gastritis is described as resulting from conditions that alter mucosal barriers like decreased blood flow or ischemia from shock/trauma. Mallory-Weiss tears occur when forceful vomiting causes tears in the gastric mucosa at the gastroesophageal junction.
Gastrointestinal (GI) bleeding refers to any bleeding that originates in the GI tract, ranging from microscopic to massive bleeding. GI bleeding can occur from the mouth to the anus and have various causes including ulcers, cancers, and vascular abnormalities. Signs of upper GI bleeding include vomiting blood while signs of lower GI bleeding include bloody stool. Management may involve blood transfusions, endoscopy, and surgery to control active bleeding.
Portal hypertension, liver cirrhosis and liver transplantAnshu Yadav
Portal hypertension occurs when blood pressure within the portal venous system increases. It is commonly caused by liver cirrhosis and affects 5-10% of patients in developed countries. Cirrhosis results from chronic liver damage and scarring of the liver tissue. It can be caused by alcoholism, viral hepatitis, NASH, or genetic diseases. Common signs include fatigue, abdominal pain, and jaundice. Treatment focuses on managing complications through medications, procedures like TIPS or banding of varices, and potentially liver transplantation.
Approach to patient with upper GIT bleeding
Approach to patient with upper GIT bleeding
Approach to patient with upper GIT bleeding
Approach to patient with upper GIT bleeding
Upper gastrointestinal bleeding can originate from the esophagus, stomach, or duodenum. Common causes include acute erosive gastritis, portal hypertension, and peptic ulcers. Males are affected more than females. Scoring systems like the Blatchford score can help predict the need for intervention. Emergency management involves intravenous fluids, blood transfusions, endoscopy for diagnosis and treatment. For variceal bleeding, vasoconstrictors, balloon tamponade, band ligation, and antibiotics are used. Preventing recurrent bleeding involves treating H. pylori and avoiding NSAIDs when possible.
1. The document discusses gastrointestinal bleeding, describing its various presentations including hematemesis, melena, hematochezia, occult blood in stools, and chronic blood loss/anemia.
2. Upper GI bleeding occurs above the ligament of Treitz and can cause hematemesis or melena, while lower GI bleeding occurs below and causes melena and hematochezia but no hematemesis.
3. Common causes of upper GI bleeding include peptic ulcer disease, gastritis, and esophageal varices, while common causes of lower GI bleeding include hemorrhoids, diverticulosis, and polyps.
Approach to Management of Upper Gastrointestinal (GI) BleedingArun Vasireddy
Upper gastrointestinal bleeding is gastrointestinal bleeding in the upper gastrointestinal tract, commonly defined as bleeding arising from the esophagus, stomach, or duodenum. Blood may be observed in vomit (hematemesis) or in altered form in the stool (melena). Depending on the severity of the blood loss, there may be symptoms of insufficient circulating blood volume and shock. As a result, upper gastrointestinal bleeding is considered a medical emergency and typically requires hospital care for urgent diagnosis and treatment. Upper gastrointestinal bleeding can be caused by peptic ulcers, gastric erosions, esophageal varices, and some rarer causes such as gastric cancer.
The initial assessment includes measurement of the blood pressure and heart rate, as well as blood tests to determine hemoglobin concentration. In significant bleeding, fluid replacement is often required, as well as blood transfusion, before the source of bleeding can be determined by endoscopy of the upper digestive tract with an esophagogastroduodenoscopy. Depending on the source, endoscopic therapy can be applied to reduce rebleeding risk. Specific medical treatments (such as proton pump inhibitors for peptic ulcer disease) or procedures (such as TIPS for variceal hemorrhage) may be used. Recurrent or refractory bleeding may lead to need for surgery, although this has become uncommon as a result of improved endoscopic and medical treatment.
This document discusses upper gastrointestinal bleeding, including its definition, etiologies, presentations, and management. The main causes of upper GI bleeding are esophageal and gastric varices, peptic ulcers, erosive gastritis, and Dieulafoy's lesions. Clinical manifestations include melena, hematemesis, and hematochezia. Management involves resuscitation, endoscopy to determine the source of bleeding, and treatments specific to the cause such as band ligation for varices, sclerotherapy for ulcers, and antisecretory drugs for erosions. Refractory bleeding may require transjugular intrahepatic portosystemic shunt placement or surgery.
Upper GI bleeding refers to bleeding proximal to the ligament of Treitz and can present as hematemesis, melena, or hematochezia. Initial assessment involves ABCs and resuscitation followed by endoscopy to identify the source of bleeding which is most commonly a peptic ulcer. Endoscopy allows for cauterization or injection to stop bleeding from ulcers or varices. If endoscopy fails or is contraindicated, angiography or surgery may be required while prevention involves testing and treating H. pylori or reducing NSAID use.
The document outlines various procedures and treatments for gastrointestinal bleeding including:
1) Establishing IV access and administering fluids, blood transfusions, vasopressors, antibiotics, and performing endoscopy for diagnosis and treatment.
2) Endoscopic procedures include band ligation, coagulation, and injection therapies to stop active bleeding.
3) Long term management involves eliminating risk factors, treating H. pylori infections, and using proton pump inhibitors.
This document summarizes the management of upper gastrointestinal bleed. It begins with two clinical scenarios of patients presenting with GI bleed and then covers the epidemiology, causes, signs and symptoms, risk scores for prognosis, and approaches to treatment. It emphasizes the importance of early endoscopy and acid suppression treatment. Medications discussed include PPIs, somatostatin analogs like octreotide, terlipressin, antibiotics and tranexamic acid which is being studied in the HALT-IT trial to reduce mortality from GI bleed. Discharge instructions include avoiding NSAIDs and treating H. pylori infection.
The Role of PPIS Which One is The Best for Acute Upper GI Bleeding?Mangatas Manalu-Tiga
This document discusses the role of proton pump inhibitors (PPIs) in treating upper gastrointestinal bleeding. It begins by defining upper GI bleeding and noting that the majority of GI bleeds originate in the upper GI tract. It then discusses the differential diagnosis of upper GI bleeding and lists common causes such as esophageal varices, gastric ulcers, and duodenal ulcers. The document emphasizes that maintaining a stomach pH above 6 is important for preventing rebleeding because it allows blood clots to form stabilly. Proton pump inhibitors are the treatment of choice for raising gastric pH and preventing rebleeding because they more effectively suppress acid secretion compared to histamine-2 receptor antagonists.
A 59-year-old Chinese man was admitted to the hospital for vomiting blood. He has a history of hepatitis C and is a smoker, drinker, and former drug user. Physical examination found abdominal distension with fluid thrill and shifting dullness. Testing showed signs of liver dysfunction. The provisional diagnosis is esophageal varices secondary to liver disease, likely cirrhosis. Esophageal varices form as a result of portal hypertension in liver disease and can bleed, potentially severely. Treatment focuses on stopping the bleeding and lowering portal pressure through various medical and procedural options.
This document discusses hematemesis and melena, which are symptoms of gastrointestinal bleeding. It defines hematemesis as vomiting of blood and melena as black tarry stool containing digested blood. The document lists risk factors for death from acute upper GI bleeding such as advanced age, shock, comorbidities, and endoscopic findings indicating severe bleeding. It discusses causes of bleeding including peptic ulcers and varices. Treatment approaches covered include intravenous fluids, blood transfusion, endoscopy for diagnosis and treatment, and pharmacological therapies depending on the cause of bleeding.
Gastrointestinal bleeding (GI bleed), also known as gastrointestinal hemorrhage, is all forms of bleeding in the gastrointestinal tract, from the mouth to the rectum. When there is significant blood loss over a short time, symptoms may include vomiting red blood, vomiting black blood, bloody stool, or black stool.
This document discusses upper gastrointestinal bleeding, including its definition, causes, risk factors, evaluation, and management approaches. It covers various pathologies that can cause upper GI bleeding such as peptic ulcer disease, Mallory-Weiss tears, esophagitis, and Dieulafoy's lesions. Evaluation involves risk stratification scores, resuscitation, endoscopy for localization and treatment. Management depends on the cause and includes medical therapies like PPIs, endoscopic interventions, angioembolization, and surgery.
This document provides an overview of upper gastrointestinal hemorrhage. It discusses the initial assessment and resuscitation of patients, including fluid resuscitation and blood transfusions. The identification of the source of bleeding is important, and endoscopy is the gold standard investigation. The main causes of upper GI bleeding are discussed, including peptic ulcer disease, variceal bleeding, and Mallory-Weiss tears. Treatment options are outlined for each cause, including pharmacologic, endoscopic, interventional, and surgical approaches.
- Gastrointestinal bleeding (GIB) accounts for around 150 hospitalizations per 100,000 people annually in the United States, with upper GIB being more common than lower GIB. The incidence and mortality of GIB have decreased in recent decades primarily due to a reduction in upper GIB.
- GIB can present as overt or occult bleeding. Overt GIB involves visible bleeding while occult GIB is identified through symptoms of blood loss or anemia. GIB is also categorized by the site of bleeding as upper, lower, or obscure GIB.
- Common causes of upper GIB include peptic ulcers, Mallory-Weiss tears, esophageal varices, and hemorrhagic
This document discusses gastrointestinal bleeding, including defining acute upper and lower GI bleeding, assessing the severity of bleeding, determining the location of bleeding, differential diagnoses, and management approaches. It provides details on the signs and symptoms of upper and lower GI bleeding, common causes, and first aid measures. The management of GI bleeding involves assessing the patient's hemodynamic status, localizing the bleeding source, checking blood work, addressing risk factors, and stopping active bleeding while preventing recurrence.
esophageal varices are the second most common cause of upper GI bleed after PUD.These are actually the dilated veins which occur secondary to increase in the pressure in the portal circulation called as Portal Hypertension..
The document discusses upper gastrointestinal bleeding, including its definition, causes, risk factors, diagnosis, and management. Some key points:
- Upper GI bleeding is defined as bleeding above the ligament of Treitz in the duodenum. Common causes include peptic ulcers, esophageal varices, and gastritis.
- Risk factors include NSAID/aspirin use, H. pylori infection, and older age. Endoscopy within 24 hours can identify the bleeding source in 90% of cases.
- Initial management involves nasogastric aspiration, IV fluids, blood transfusions, and endoscopy for high risk patients. Terlipressin or octreotide can help control var
The document discusses the arterial supply, portal vein, and common causes of gastrointestinal bleeding including esophageal varices, peptic ulcers, erosive gastritis, gastric cancer, and Mallory-Weiss tears. It provides details on the clinical features, investigations, risk factors, and management approaches for upper and lower gastrointestinal bleeding.
This document summarizes the management of gastrointestinal bleeding. It distinguishes between upper and lower GI bleeding, noting that upper bleeding is more common and causes include peptic ulcers and esophageal varices. Initial resuscitation focuses on airway, breathing, circulation. Endoscopy is important for diagnosis and treatment. Lower GI bleeding has different common causes like diverticulosis and polyps. Management involves resuscitation, stopping anticoagulants, and endoscopic or radiological localization and treatment of the bleeding site.
This document discusses liver abscesses, including their classification, presentation, risk factors, and management. There are three main types of liver abscess - pyogenic (polymicrobial), amoebic (caused by Entamoeba histolytica), and fungal. Common symptoms include fever, right upper quadrant pain, and tender hepatomegaly. Risk factors vary depending on the type but include diabetes, cancer, travel to endemic areas, and alcohol use. Treatment involves drainage of pus via percutaneous or surgical methods along with antibiotics. Factors determining the need for drainage versus medical management alone depend on the size and characteristics of the abscess.
Portal hypertension, liver cirrhosis and liver transplantAnshu Yadav
Portal hypertension occurs when blood pressure within the portal venous system increases. It is commonly caused by liver cirrhosis and affects 5-10% of patients in developed countries. Cirrhosis results from chronic liver damage and scarring of the liver tissue. It can be caused by alcoholism, viral hepatitis, NASH, or genetic diseases. Common signs include fatigue, abdominal pain, and jaundice. Treatment focuses on managing complications through medications, procedures like TIPS or banding of varices, and potentially liver transplantation.
Approach to patient with upper GIT bleeding
Approach to patient with upper GIT bleeding
Approach to patient with upper GIT bleeding
Approach to patient with upper GIT bleeding
Upper gastrointestinal bleeding can originate from the esophagus, stomach, or duodenum. Common causes include acute erosive gastritis, portal hypertension, and peptic ulcers. Males are affected more than females. Scoring systems like the Blatchford score can help predict the need for intervention. Emergency management involves intravenous fluids, blood transfusions, endoscopy for diagnosis and treatment. For variceal bleeding, vasoconstrictors, balloon tamponade, band ligation, and antibiotics are used. Preventing recurrent bleeding involves treating H. pylori and avoiding NSAIDs when possible.
1. The document discusses gastrointestinal bleeding, describing its various presentations including hematemesis, melena, hematochezia, occult blood in stools, and chronic blood loss/anemia.
2. Upper GI bleeding occurs above the ligament of Treitz and can cause hematemesis or melena, while lower GI bleeding occurs below and causes melena and hematochezia but no hematemesis.
3. Common causes of upper GI bleeding include peptic ulcer disease, gastritis, and esophageal varices, while common causes of lower GI bleeding include hemorrhoids, diverticulosis, and polyps.
Approach to Management of Upper Gastrointestinal (GI) BleedingArun Vasireddy
Upper gastrointestinal bleeding is gastrointestinal bleeding in the upper gastrointestinal tract, commonly defined as bleeding arising from the esophagus, stomach, or duodenum. Blood may be observed in vomit (hematemesis) or in altered form in the stool (melena). Depending on the severity of the blood loss, there may be symptoms of insufficient circulating blood volume and shock. As a result, upper gastrointestinal bleeding is considered a medical emergency and typically requires hospital care for urgent diagnosis and treatment. Upper gastrointestinal bleeding can be caused by peptic ulcers, gastric erosions, esophageal varices, and some rarer causes such as gastric cancer.
The initial assessment includes measurement of the blood pressure and heart rate, as well as blood tests to determine hemoglobin concentration. In significant bleeding, fluid replacement is often required, as well as blood transfusion, before the source of bleeding can be determined by endoscopy of the upper digestive tract with an esophagogastroduodenoscopy. Depending on the source, endoscopic therapy can be applied to reduce rebleeding risk. Specific medical treatments (such as proton pump inhibitors for peptic ulcer disease) or procedures (such as TIPS for variceal hemorrhage) may be used. Recurrent or refractory bleeding may lead to need for surgery, although this has become uncommon as a result of improved endoscopic and medical treatment.
This document discusses upper gastrointestinal bleeding, including its definition, etiologies, presentations, and management. The main causes of upper GI bleeding are esophageal and gastric varices, peptic ulcers, erosive gastritis, and Dieulafoy's lesions. Clinical manifestations include melena, hematemesis, and hematochezia. Management involves resuscitation, endoscopy to determine the source of bleeding, and treatments specific to the cause such as band ligation for varices, sclerotherapy for ulcers, and antisecretory drugs for erosions. Refractory bleeding may require transjugular intrahepatic portosystemic shunt placement or surgery.
Upper GI bleeding refers to bleeding proximal to the ligament of Treitz and can present as hematemesis, melena, or hematochezia. Initial assessment involves ABCs and resuscitation followed by endoscopy to identify the source of bleeding which is most commonly a peptic ulcer. Endoscopy allows for cauterization or injection to stop bleeding from ulcers or varices. If endoscopy fails or is contraindicated, angiography or surgery may be required while prevention involves testing and treating H. pylori or reducing NSAID use.
The document outlines various procedures and treatments for gastrointestinal bleeding including:
1) Establishing IV access and administering fluids, blood transfusions, vasopressors, antibiotics, and performing endoscopy for diagnosis and treatment.
2) Endoscopic procedures include band ligation, coagulation, and injection therapies to stop active bleeding.
3) Long term management involves eliminating risk factors, treating H. pylori infections, and using proton pump inhibitors.
This document summarizes the management of upper gastrointestinal bleed. It begins with two clinical scenarios of patients presenting with GI bleed and then covers the epidemiology, causes, signs and symptoms, risk scores for prognosis, and approaches to treatment. It emphasizes the importance of early endoscopy and acid suppression treatment. Medications discussed include PPIs, somatostatin analogs like octreotide, terlipressin, antibiotics and tranexamic acid which is being studied in the HALT-IT trial to reduce mortality from GI bleed. Discharge instructions include avoiding NSAIDs and treating H. pylori infection.
The Role of PPIS Which One is The Best for Acute Upper GI Bleeding?Mangatas Manalu-Tiga
This document discusses the role of proton pump inhibitors (PPIs) in treating upper gastrointestinal bleeding. It begins by defining upper GI bleeding and noting that the majority of GI bleeds originate in the upper GI tract. It then discusses the differential diagnosis of upper GI bleeding and lists common causes such as esophageal varices, gastric ulcers, and duodenal ulcers. The document emphasizes that maintaining a stomach pH above 6 is important for preventing rebleeding because it allows blood clots to form stabilly. Proton pump inhibitors are the treatment of choice for raising gastric pH and preventing rebleeding because they more effectively suppress acid secretion compared to histamine-2 receptor antagonists.
A 59-year-old Chinese man was admitted to the hospital for vomiting blood. He has a history of hepatitis C and is a smoker, drinker, and former drug user. Physical examination found abdominal distension with fluid thrill and shifting dullness. Testing showed signs of liver dysfunction. The provisional diagnosis is esophageal varices secondary to liver disease, likely cirrhosis. Esophageal varices form as a result of portal hypertension in liver disease and can bleed, potentially severely. Treatment focuses on stopping the bleeding and lowering portal pressure through various medical and procedural options.
This document discusses hematemesis and melena, which are symptoms of gastrointestinal bleeding. It defines hematemesis as vomiting of blood and melena as black tarry stool containing digested blood. The document lists risk factors for death from acute upper GI bleeding such as advanced age, shock, comorbidities, and endoscopic findings indicating severe bleeding. It discusses causes of bleeding including peptic ulcers and varices. Treatment approaches covered include intravenous fluids, blood transfusion, endoscopy for diagnosis and treatment, and pharmacological therapies depending on the cause of bleeding.
Gastrointestinal bleeding (GI bleed), also known as gastrointestinal hemorrhage, is all forms of bleeding in the gastrointestinal tract, from the mouth to the rectum. When there is significant blood loss over a short time, symptoms may include vomiting red blood, vomiting black blood, bloody stool, or black stool.
This document discusses upper gastrointestinal bleeding, including its definition, causes, risk factors, evaluation, and management approaches. It covers various pathologies that can cause upper GI bleeding such as peptic ulcer disease, Mallory-Weiss tears, esophagitis, and Dieulafoy's lesions. Evaluation involves risk stratification scores, resuscitation, endoscopy for localization and treatment. Management depends on the cause and includes medical therapies like PPIs, endoscopic interventions, angioembolization, and surgery.
This document provides an overview of upper gastrointestinal hemorrhage. It discusses the initial assessment and resuscitation of patients, including fluid resuscitation and blood transfusions. The identification of the source of bleeding is important, and endoscopy is the gold standard investigation. The main causes of upper GI bleeding are discussed, including peptic ulcer disease, variceal bleeding, and Mallory-Weiss tears. Treatment options are outlined for each cause, including pharmacologic, endoscopic, interventional, and surgical approaches.
- Gastrointestinal bleeding (GIB) accounts for around 150 hospitalizations per 100,000 people annually in the United States, with upper GIB being more common than lower GIB. The incidence and mortality of GIB have decreased in recent decades primarily due to a reduction in upper GIB.
- GIB can present as overt or occult bleeding. Overt GIB involves visible bleeding while occult GIB is identified through symptoms of blood loss or anemia. GIB is also categorized by the site of bleeding as upper, lower, or obscure GIB.
- Common causes of upper GIB include peptic ulcers, Mallory-Weiss tears, esophageal varices, and hemorrhagic
This document discusses gastrointestinal bleeding, including defining acute upper and lower GI bleeding, assessing the severity of bleeding, determining the location of bleeding, differential diagnoses, and management approaches. It provides details on the signs and symptoms of upper and lower GI bleeding, common causes, and first aid measures. The management of GI bleeding involves assessing the patient's hemodynamic status, localizing the bleeding source, checking blood work, addressing risk factors, and stopping active bleeding while preventing recurrence.
esophageal varices are the second most common cause of upper GI bleed after PUD.These are actually the dilated veins which occur secondary to increase in the pressure in the portal circulation called as Portal Hypertension..
The document discusses upper gastrointestinal bleeding, including its definition, causes, risk factors, diagnosis, and management. Some key points:
- Upper GI bleeding is defined as bleeding above the ligament of Treitz in the duodenum. Common causes include peptic ulcers, esophageal varices, and gastritis.
- Risk factors include NSAID/aspirin use, H. pylori infection, and older age. Endoscopy within 24 hours can identify the bleeding source in 90% of cases.
- Initial management involves nasogastric aspiration, IV fluids, blood transfusions, and endoscopy for high risk patients. Terlipressin or octreotide can help control var
The document discusses the arterial supply, portal vein, and common causes of gastrointestinal bleeding including esophageal varices, peptic ulcers, erosive gastritis, gastric cancer, and Mallory-Weiss tears. It provides details on the clinical features, investigations, risk factors, and management approaches for upper and lower gastrointestinal bleeding.
This document summarizes the management of gastrointestinal bleeding. It distinguishes between upper and lower GI bleeding, noting that upper bleeding is more common and causes include peptic ulcers and esophageal varices. Initial resuscitation focuses on airway, breathing, circulation. Endoscopy is important for diagnosis and treatment. Lower GI bleeding has different common causes like diverticulosis and polyps. Management involves resuscitation, stopping anticoagulants, and endoscopic or radiological localization and treatment of the bleeding site.
This document discusses liver abscesses, including their classification, presentation, risk factors, and management. There are three main types of liver abscess - pyogenic (polymicrobial), amoebic (caused by Entamoeba histolytica), and fungal. Common symptoms include fever, right upper quadrant pain, and tender hepatomegaly. Risk factors vary depending on the type but include diabetes, cancer, travel to endemic areas, and alcohol use. Treatment involves drainage of pus via percutaneous or surgical methods along with antibiotics. Factors determining the need for drainage versus medical management alone depend on the size and characteristics of the abscess.
This document discusses the management of surgical emergencies. It begins by outlining the signs of shock and how to assess patients presenting with shock. It then discusses the immediate management of shock, including fluid resuscitation and appropriate investigations. Specific investigations discussed include full blood count, electrolytes, blood glucose, and coagulation profile. The document also discusses appropriate intravenous fluid selection and oxygen delivery. Principles of management are discussed for conditions like upper gastrointestinal bleeding and lower gastrointestinal bleeding.
This document provides an overview of acute gastrointestinal bleeding. It defines upper gastrointestinal bleeding and discusses its causes, including variceal and non-variceal sources. Signs and symptoms are outlined. The approach involves taking a thorough history and physical exam. Key lab tests include CBC, LFTs, coagulation panels and endoscopy. Treatment depends on the bleeding source, and may include endoscopic methods, radiological embolization, surgery, or medications like PPIs and vasoactive drugs. Complications are also reviewed.
This document discusses treatment options for bleeding duodenal ulcers. Endoscopic therapy can identify patients at low risk of rebleeding and reduce the likelihood of recurrent bleeding through procedures like epinephrine injection, thermal coagulation, and hemoclipping. Urgent endoscopy is the first-line treatment and is successful in stopping bleeding in about 90% of cases. Medical management involves acid suppression through proton pump inhibitors or H2 blockers to aid hemostasis. For patients where endoscopic therapy fails, options include embolization or surgical procedures like vagotomy with pyloroplasty.
portal hypertension UG class by Prof. Ajay Khanna, IMS, BHU, Varanasi, IndiaDivya Khanna
This document provides information on portal hypertension, including its definition, anatomy, pathophysiology, etiology, clinical features, investigations, treatment of variceal bleeding, ascites, encephalopathy, Budd-Chiari syndrome, and various surgical procedures. Portal hypertension is defined as a portal venous pressure greater than 12 mmHg and is characterized by the development of portosystemic collaterals. Common causes include liver cirrhosis, portal vein thrombosis, and Budd-Chiari syndrome. Treatment involves reducing portal pressure, treating complications, and addressing the underlying liver disease.
Upper gastrointestinal bleeding remains a common emergency presentation. Evidence-based guidelines support aggressive resuscitation and stabilization of patients, followed by upper endoscopy to diagnose the source of bleeding and attempt endoscopic treatment when possible. The most common causes of upper GI bleeding emergencies are peptic ulcers and esophageal varices. Ulcer bleeding is typically treated endoscopically with epinephrine injection, thermal coagulation, or clipping. Variceal bleeding differs in treatment depending on the location - esophageal varices are banded or sclerosed while gastric varices often require tissue adhesive injection or TIPS. Surgical or radiological intervention may be needed if endoscopic therapies fail to achieve hemostasis.
This document provides an overview of the assessment and management of abdominal trauma. It discusses the classification of abdominal trauma as blunt or penetrating, and the classification of patients as hemodynamically normal, stable, or unstable. Absolute indications for an emergency laparotomy are listed. Diagnostic tools like FAST scan, DPL, and CT scan are outlined. Organ-specific injuries and treatments are covered including liver, spleen, small bowel, colon, pancreas, duodenum, kidney, and retroperitoneal hematomas. Damage control surgery principles, abdominal compartment syndrome, and antibiotics for penetrating abdominal trauma are also summarized.
Portal hypertension occurs when blood pressure in the portal vein system, which drains blood from the gastrointestinal tract to the liver, increases above normal levels. It is defined as a hepatic venous pressure gradient greater than 15 mmHg. Two key factors that contribute to portal hypertension are increased vascular resistance and increased blood flow. Investigation may include blood tests and imaging of the liver, portal system, and varices. Complications include variceal bleeding, ascites, and hepatic encephalopathy. Treatment depends on severity but may involve medication, endoscopic procedures, transjugular intrahepatic portosystemic shunt placement, or surgical shunting of blood flow to reduce portal pressure.
FCPS Part 2 Gen Surg Past Paper Aug 2018.pdfAfaq Ali
1. This document discusses various medical cases and their recommended treatments. It includes cases related to posterior urethral valves, developmental dysplasia of the hip, cellulitis, stafne bone cysts, splenic trauma, liver tears, nephrectomy pathology, parotid swelling, ranulas, parotidectomy histopathology, hyperhidrosis, hidradenitis suppurativa, tongue cancer, hyperparathyroidism, glomus tumors, hernias, HIV transmission, breast cancer staging and treatment, annular pancreas, appendicitis, pancreatic cysts, mucinous cysts, hydatid cysts, gallbladder cancer staging, variceal bleeding, nausea/
This document discusses the principles and techniques of laparoscopic surgery. It begins with an introduction to minimal access surgery and its aims of reducing somatic and psychological trauma while allowing for shorter hospital stays and faster recovery. The document then covers the categories of minimally invasive procedures and diagnostic and therapeutic applications of laparoscopic surgery. It provides details on preoperative evaluation and preparation, creating pneumoperitoneum, intraoperative equipment and techniques, postoperative care, and examples of common laparoscopic procedures like cholecystectomy, hernia repair, and fundoplication. Throughout it includes diagrams to illustrate surgical anatomy and procedure steps.
Portal Hypertension and its Management is discussed. Key points include:
- Portal hypertension results from increased resistance to portal blood flow from liver fibrosis and vasoconstriction.
- Clinical presentation includes variceal bleeding, ascites, and encephalopathy. Imaging helps evaluate portal vein anatomy and pressure.
- Treatment depends on severity but includes medications, endoscopic therapies like banding, transjugular intrahepatic portosystemic shunt (TIPS), and surgeries like shunts.
- Selective shunts like distal splenorenal shunt aim to decompress varices while maintaining some portal blood flow to the liver, reducing risks of encephalopathy and
Upper GI bleeding (UGIB) is a common cause of hospitalization that can be life-threatening. The main causes are peptic ulcer disease, esophageal varices, and erosive mucosal disease. Patients presenting with UGIB require resuscitation focusing on airway, breathing, and circulation. Early endoscopy within 24 hours is recommended to determine the source of bleeding and apply endoscopic treatments as needed. Post-endoscopy management involves monitoring for rebleeding, administering PPIs or other drugs to prevent rebleeding, and treating the underlying cause of bleeding.
This document discusses the peri-operative anesthetic management of patients with pheochromocytoma. It begins with an introduction to pheochromocytoma, including its origin, symptoms, diagnosis, and risks of surgery. It then covers pre-operative preparation including pharmacological control of catecholamines and optimized testing/monitoring. Specific anesthetic considerations are outlined such as drugs to avoid and techniques/medications that can be used safely. Critical periods during surgery and post-operative monitoring and risks are also summarized. The conclusion reinforces that successful management of pheochromocytoma remains challenging and requires a multidisciplinary team approach.
This document outlines principles of trauma laparotomy and damage control surgery. It discusses relevant anatomy, indications for laparotomy following penetrating or blunt trauma, and the operative sequence including access, exploration, hemorrhage control, and damage control or definitive repair. It provides details on approaches and management of injuries to various abdominal organs. The goal is to control hemorrhage and contamination while optimizing the patient's physiology for subsequent definitive care.
This document summarizes the management of upper GI hemorrhage. It outlines the steps to take which include obtaining a complete history and physical exam, performing laboratory tests, considering radiological scans, stabilizing the patient, identifying the source of bleeding through endoscopy, and various pharmacological and endoscopic interventions depending on the underlying cause of bleeding such as PPIs, octreotide, angiography, embolization, surgery, or TIPS procedure. Refractory cases may require repeat endoscopy, angiography, embolization or surgery.
acute upper gi bleeding approch and managmentssuserc44fa8
This document discusses upper gastrointestinal bleeding, including its definition, causes, and management. The causes are categorized as nonvariceal bleeding (80% of cases, most commonly from peptic ulcer disease) or bleeding related to portal hypertension (20% of cases, usually from gastroesophageal varices). Early endoscopy within 24 hours is recommended to identify the source of bleeding and guide treatment. Treatment depends on the specific cause but may include endoscopic therapies like epinephrine injection or thermal coagulation, as well as medications like PPIs. Surgery is considered if endoscopic treatment fails or for high risk lesions.
This document provides an overview of the anatomy, physiology, and common diseases of the esophagus. It begins with the learning objectives which are to understand the anatomy/physiology and clinical features of benign and malignant esophageal diseases. It then covers topics such as surgical anatomy, physiology, symptoms, investigations, congenital anomalies, foreign bodies, perforations, gastroesophageal reflux disease, hiatal hernia, motility disorders, and diverticula.
This document provides an overview of the anatomy, physiology, and common diseases of the esophagus. It begins with the learning objectives which are to understand the anatomy/physiology and clinical features of benign and malignant esophageal diseases. It then covers topics such as surgical anatomy, physiology, symptoms, investigations, congenital anomalies, foreign bodies, perforations, gastroesophageal reflux disease, hiatal hernia, motility disorders, and diverticula.
Similar to Treatment of Upper Gastrointestinal Bleeding (20)
This document discusses various oral diseases and their causes, including:
- Angular stomatitis and cheilosis, which are redness and cracking around the mouth caused by deficiencies in niacin, riboflavin, and iron.
- Glossitis, which is inflammation of the tongue caused by deficiencies in several vitamins including B12 and iron.
- Burton lines on gums and oral pigmentation from conditions like Addison's disease or medications.
- Bleeding gums from vitamin C deficiency, periodontitis, gingivitis, or blood disorders.
- Macroglossia (enlarged tongue) from causes like tongue cancer, acromegaly, or amyloidosis.
Angina pectoris is a condition where symptoms of chest pain or discomfort occur due to reduced blood flow to the heart muscle. The document discusses the symptoms of angina and precipitating factors like unaccustomed physical exertion. It outlines the New York Heart Association classification system for functional limitations caused by angina. The diagnosis of angina involves tests like electrocardiograms, treadmill tests, bloodwork, echocardiograms, and coronary angiography. Treatment options mentioned include bed rest, oxygen, nitrates, antiplatelet medications, beta blockers, calcium channel blockers, ACE inhibitors, statins, antithrombins, and procedures like angioplasty or bypass surgery.
Coronary heart disease (CHD), also known as ischemic heart disease, is caused by a buildup of fat, cholesterol, and other substances in the coronary arteries leading to atherosclerosis. The most common symptom is chest pain. Risk factors include physical inactivity, smoking, obesity, diabetes, and high blood pressure. Diagnosis involves tests like ECG, echocardiogram, stress test, and angiogram. Treatment includes lifestyle changes, medications to lower cholesterol and blood pressure, and cardiac surgery procedures to improve blood flow.
The prevalence of depression in the UK doubled from 1 in 10 (9.7%) before the pandemic to 1 in 5 (19.7%) during the 2020 lockdowns according to National Statistics. Severity of obsessive compulsive disorder (OCD) increased by 72% for those experiencing lockdowns. The document discusses the negative effects of lockdowns on mental health in the UK during the COVID-19 pandemic.
Coauthors: Dr Christa Maria Joel, Dr Hira Zahid, Dr Michael Oludipe, Dr Qudroh, Dr Gilda Philip, Ms Philo Mary Fernandez
Module: Effects of Lifestyle on Health
Supervisors: Ms Jane Tobias and Dr Daniel Boakye
University of the West of Scotland
Coauthors: Dr Christa Maria Joel, Dr Hira Zahid, Dr Michael Oludipe, Dr Qudroh, Dr Gilda Philip, Ms Philo Mary Fernandez
Module: Effects of Lifestyle on Health
Supervisors: Ms Jane Tobias and Dr Daniel Boakye
University of the West of Scotland
The document discusses the relationship between diet and health. It defines a healthy diet and outlines how diet can both aggravate and regulate disease. Poor diet is linked to several health issues like heart disease, diabetes, and cancer. The Scottish government aims to restrict marketing of unhealthy foods and increase availability of healthy options to reduce diet-related illnesses in the population.
The document lists various surgical and medical causes that can result in abdominal pain, such as gallstones, ulcers, infections of the urinary tract or reproductive organs, vascular issues like aneurysms, and cancers. It also mentions psychiatric, musculoskeletal, neurological, pulmonary, endocrine, and blood disorders as potential causes. The management section recommends medications like hyoscine and dicyclomine to treat colicky pain, antibiotics for infections, and surgery for trauma or obstructions.
This document outlines the causative factors, pathophysiology, symptoms, and treatment of gastroesophageal reflux disease (GERD). The causative factors include diet, exercise, obesity, hiatal hernia, pregnancy, and H. pylori infection. The pathophysiology is decreased lower esophageal sphincter tone allowing gastric acid reflux, which over time can lead to Barrett's esophagus if left untreated. Common symptoms are heartburn, chest pain, belching, swallowing difficulty, and sour taste in mouth. Treatment involves lifestyle changes like dietary modifications and weight loss as well as medications like antacids, H2 blockers, and proton pump inhibitors.
This document discusses chronic obstructive pulmonary disease (COPD), which typically affects people aged 40-50 who smoke. Laboratory tests like sputum exams, ECGs, and echocardiograms can detect microorganisms and check for related cardiac or pulmonary issues. Treatment involves quitting smoking, supplemental oxygen, bronchodilators, corticosteroids during exacerbations, antibiotics for acute issues, and potentially surgery like lung transplants or reduction procedures for severe cases.
The document outlines signs and symptoms, treatment, and laboratory tests for depression. Key signs and symptoms include sadness, guilt, worthlessness, sleep and appetite disturbances, fatigue, suicidal thoughts, and decreased concentration. Treatments include cognitive behavioral therapy, antidepressant medication, and potentially electroconvulsive therapy for severe cases. Antidepressants require gradual dose reduction due to withdrawal risk. Laboratory tests that may be done include complete blood count, thyroid and vitamin levels, and toxicology screening.
This document discusses the treatment and signs and symptoms of atopic dermatitis. Treatment involves topical corticosteroids for mild to moderate cases and systemic corticosteroids or immunosuppressants for severe cases. Signs include severe itching and oozing rash in common areas. Diagnosis involves allergy tests showing dust mite sensitivity and lab findings like eosinophilia and elevated IgE levels.
Author: Dr Christa Maria Joel
Module: Master of Public Health Dissertation
Supervisors: Dr William Mackay Gordie and Dr Steven Kelly
University of the West of Scotland
Presentation describing the dissertation undertaken.
Author: Dr Christa Maria Joel
Module: MPH Dissertation
Supervisors: Dr William Mackay Gordie and Dr Steven Kelly
University of the West of Scotland
Co-authors: Dr Christa, Mr Akhil Shaji, Mr Elijah Kwame
Module: Principles of Infection and Disease Control
Supervisor: Mr William Mackay Gordie and Ms Fiona Hernandez
University of the West of Scotland
Author: Dr Christa Maria Joel
Module: Principles of Infection and Disease Control
Supervisor: Dr William Mackay Gordie and Ms Fiona Hernandez
University of the West of Scotland
This document provides details about an assignment for a module on the application of eHealth in dementia. The assignment requires a 4,000 word essay (up to 4,400 words) that critically examines the use and application of eHealth in an area of practice, such as focusing on a case example involving the management of a chronic condition like diabetes. The submission deadline is May 3, 2022. The document also includes sections for the student to fill out with their word count, originality score, banner ID, and whether an extension was granted. It asks how previous feedback was used and what specific issues the student would like feedback on.
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...rightmanforbloodline
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central19various
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
2. General
Medical therapy
Endoscopic therapy
CT angiography guided embolization
Surgical treatment
3. General therapy
IV fluids
Catheterisation
Ryle’s tube aspiration: to reduce
vomiting and to prevent aspiration
of stomach contents into lungs.
Blood transfusion
4. Medical therapy
Injection ranitidine IV 50mg 8th
hourly or famotidine IV,
omeprazole IV and pantoprazole
IV.
Antifibrinolytics like tranexamic
acid and EACA.
Somatostatin or octreotide, PPI
infusion.
5. Endoscopic therapy
First line of therapy in all upper GI
bleed.
Laser coagulation- can arrest bleeding
without direct tissue contact.
Sclerotherapy- epinephrine (1:10000)
and 2% ethanolamine.
Haemoclip application
7. Surgical management
For peptic ulcer:
- Finney’s pyloroplasty:
gastroduodenostomy between anterior
surface of stomach and duodenum
Single inverted
u or v shaped
incision is
made through
prepyloric
antrum,
pylorus and 1st
part of
duodenum
Posterior inner
layer of
gastroduodenal
anastomosis is
completed with
a continuous
full thickness
suture.
Anterior inner
layer is
completed with
a continuous
inverting
suture.
9. For varices:
- Boerema-Crile operation:
Patient in
right in lateral
position.
Thoractomy is
done through
8th rib.
Esophagus
dissected and
isolated,
clamp applied
at cardia,
esophagus
opened
longitudinally
to hold edges
with sutures.
Varices
columns
under run
using
continuous
sutures.
Esophageal
incised muscle
layer
resutured
again.
10. - Hasaab operation: devascularisation and
splenectomy.
- Oesophageal transection: removal of lower
5cm esophagus with end to end
anastomosis.
- Siguira – Futagawa operation: vagotomy,
pyloroplasty, devascularisation and
splenectomy.
- TIPSS: artificial communication between
inflow portal vein and outflow hepatic vein.